Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Breast 5Gynecologic 2Gastrointestinal 2Thoracic 1Head & Neck 1Genitourinary 1Endocrine 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 4Pancreatic Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Genotype × Breast × Clear all
NCT05006196 2026-05-20

IMOGEN

Perspectum

Active not recruiting
1,030 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT05755269 2026-05-01

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Mayo Clinic

Terminated
19 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT05876728 2023-05-25

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

Sohag University

Unknown
100 enrolled
Breast

Breast Neoplasms

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡